Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

UFS gets more than R3 Million for HIV/Aids activities
2007-12-13

 

In the picture are some of the members of the project team. From the left are: Mr Pieter du Plessis (Finances), Ms Estelle Heideman (HIV/Aids Co-ordinator: Lengau Agri Development Centre) and Rev Jaftha.
 

UFS gets more than R3 Million for HIV/Aids activities

The Chief Directorate: Community Service at the University of the Free State (UFS) has received more than R3 million to intensify activities regarding HIV/AIDS at all UFS campuses for the next seventeen months.

Higher Education HIV/AIDS Programme (HEAIDS) contributed R3 127 207 and the UFS R615 116 towards this initiative. The money will be used to implement intervention strategies from 1 January 2008 to 31 May 2009.

“The mandate poses an extensive challenge and puts pressure on the institution, but at the same time creates some incredible opportunities for intervention,” said the Chief Director of Community Service and Project Co-ordinator, Rev. Kiepie Jaftha.

HEAIDS is a nationally co-ordinated initiative to develop and strengthen the capacity of South African higher education institutions to respond to the causes, challenges and consequences of the HIV/AIDS pandemic in the sector. It is an initiative of the Department of Education and the implementing agency is Higher Education South Africa (HESA), an organisation representing vice-chancellors of tertiary institutions in South Africa.

The proposed areas and actions of intervention are categorised into three main components, namely:

- Prevention, treatment, care and support aimed at both students and staff on all UFS campuses.
Incorporation of HIV/AIDS issues into the teaching offerings of the UFS and the development of a formal policy in this regard.

- Implementation of an integrated management information system to empower stakeholders to make decisions and adapt actions by visualising facts, actions and progress on the overall HIV/AIDS programme.

The UFS met all the requirements of HEAIDS to qualify for this funding. A five-member team was formed to come up with a document entitled The Quest for an AIDS Competent Society that met the required standards.

“Each institution of higher learning had to identify and establish a project team, appoint a project leader, assign responsibilities to members of the team with different expertise, analyse the needs of the institution, and define and agree on projects in order to access the grant,” said Rev. Jaftha.

Media Release
Issued by: Mangaliso Radebe
Assistant Director: Media Liaison
Tel: 051 401 2828
Cell: 078 460 3320
E-mail: radebemt.stg@ufs.ac.za  
13 December 2007

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept